BiotechTube
Home/CARGO Therapeutics/Gina Chapman
GC

Gina Chapman

Interim Chief Executive Officer, Board Member

CARGO Therapeutics

Therapeutic Areas

OncologyHematology

CARGO Therapeutics Pipeline

DrugIndicationPhase
CRG-022Large B-cell lymphoma (LBCL) relapsed/refractory after CD19 CAR TPhase 2
CRG-023Relapsed/Refractory B-cell Non-Hodgkin Lymphoma (NHL)Preclinical

Leadership Team at CARGO Therapeutics

BH
Brett Hall, Ph.D.
Chief Scientific Officer, Co-Founder
SA
Sunil Agarwal, M.D.
Chief Medical Officer
JR
John R. Desjarlais, Ph.D.
Chief Technology Officer
SJ
Steven J. Gannon
Chief Financial Officer
View full CARGO Therapeutics profile